News
Apple had been oddly silent about the blood oxygen feature removed from its Apple Watch models sold in the US until now.
In today’s CEO Daily: Diane Brady talks to Joe Kiani, late of Masimo, who has just become the CEO of Like Minded Labs. The ...
Masimo (NASDAQ: MASI), a global medical technology company that develops and manufactures innovative noninvasive monitoring solutions, has joined the American Heart Association Center for Health ...
BD has appointed Bilal Muhsin executive vice president and president of its future Connected Care segment, effective ...
Apple hasn’t given up on its legal battle to restore the blood oxygen sensor to the Apple Watch in the United States. Today, ...
Buying $100 In MASI: If an investor had bought $100 of MASI stock 10 years ago, it would be worth $421.06 today based on a price of $162.98 for MASI at the time of writing.
The founder of Irvine-based Masimo Corp. has been appointed of Like Minded Labs, a media technology company in Santa Monica.
Apple is making another attempt to overturn an import ban on Apple Watch models with blood oxygen monitoring capabilities, ...
Apple is fighting two high-stakes legal battles on opposite sides of the globe, challenging a US trade ban on its smartwatch ...
Like Minded Labs, a media technology company that empowers creators by transforming how they communicate, has appointed Joe Kiani, Co-Founder of Like Minded Labs, Founder of Masimo and Founder and ...
Samsung acquires Xealth to integrate wellness tools with clinical care, boosting its presence in the digital health ecosystem.
Apple is urging a US appeals court to overturn a trade ban that forced the removal of blood oxygen sensors from certain Apple Watch models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results